Douglas Reil is the co-founder and CEO at CannaKeys, whose mission is to empower patients, medical professionals, caregivers, and the industry with the tools to maximize the effectiveness of cannabis therapeutics and create an agency with regard to their applications. In this episode, Doug talks openly about his combined experience as a patient and work in the publishing industry that led to the creation of CannaKeys. In addition, he describes his vision for a new clinical model that would offer a science-based holistic, individualised approach using plant-based therapies and mind-body medicine.
He is motivated to drive this mission by his experience working with patients and as his own path incorporating cannabis to help treat his Crohn's Disease. In the cannabis industry, he has worked in compliance and community development and was the Program Director of the compassion program Mission: Compassion which provided free cannabis medicine to low-income patients. He was a founding member of the California Compassion Coalition which drove the passage of SB34 which created compliant pathways for compassionate cannabis activities in California. His thirty- five year career in publishing includes serving as Publisher and Executive Director at the nonprofit publisher North Atlantic Books and currently as Associate Publisher and Managing Director at Synergetic Press which focuses on psychedelics, regenerative practices, and social justice.
Useful Links
https://www.linkedin.com/in/douglasreil/
https://synergeticpress.com/
https://cannakeys.com
https://www.facebook.com/douglas.reil
To learn more about plants & your health from Colleen at LabAroma check out this informative PDF
Disclaimer: The information presented in this podcast is for educational purposes only, and is not intended to replace professional medical advice. Please consult your doctor if you are in need of medical care, and before making any changes to your health routine.
-02.png)
